191 related articles for article (PubMed ID: 26673327)
21. Tumor suppressive microRNA-137 negatively regulates Musashi-1 and colorectal cancer progression.
Smith AR; Marquez RT; Tsao WC; Pathak S; Roy A; Ping J; Wilkerson B; Lan L; Meng W; Neufeld KL; Sun XF; Xu L
Oncotarget; 2015 May; 6(14):12558-73. PubMed ID: 25940441
[TBL] [Abstract][Full Text] [Related]
22. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
[TBL] [Abstract][Full Text] [Related]
23. Stem Cells, Cancer, and MUSASHI in Blood and Guts.
Kharas MG; Lengner CJ
Trends Cancer; 2017 May; 3(5):347-356. PubMed ID: 28718412
[TBL] [Abstract][Full Text] [Related]
24. Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.
Sutherland JM; Fraser BA; Sobinoff AP; Pye VJ; Davidson TL; Siddall NA; Koopman P; Hime GR; McLaughlin EA
Biol Reprod; 2014 May; 90(5):92. PubMed ID: 24671879
[TBL] [Abstract][Full Text] [Related]
25. The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity.
Siddall NA; McLaughlin EA; Marriner NL; Hime GR
Proc Natl Acad Sci U S A; 2006 May; 103(22):8402-7. PubMed ID: 16717192
[TBL] [Abstract][Full Text] [Related]
26. Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
Lan L; Liu H; Smith AR; Appelman C; Yu J; Larsen S; Marquez RT; Wu X; Liu FY; Gao P; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Neufeld KL; Xu L
BMC Cancer; 2018 Aug; 18(1):809. PubMed ID: 30097032
[TBL] [Abstract][Full Text] [Related]
27. Rna-binding protein Musashi2: developmentally regulated expression in neural precursor cells and subpopulations of neurons in mammalian CNS.
Sakakibara S; Nakamura Y; Satoh H; Okano H
J Neurosci; 2001 Oct; 21(20):8091-107. PubMed ID: 11588182
[TBL] [Abstract][Full Text] [Related]
28. Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis.
Sutherland JM; Sobinoff AP; Gunter KM; Fraser BA; Pye V; Bernstein IR; Boon E; Siddall NA; De Andres LI; Hime GR; Holt JE; Graf T; McLaughlin EA
Biomolecules; 2015 Jun; 5(3):1228-44. PubMed ID: 26131972
[TBL] [Abstract][Full Text] [Related]
29. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
30. Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.
Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
[TBL] [Abstract][Full Text] [Related]
31. Suppression of intestinal tumorigenesis in
Wolfe AR; Ernlund A; McGuinness W; Lehmann C; Carl K; Balmaceda N; Neufeld KL
J Cell Sci; 2017 Feb; 130(4):805-813. PubMed ID: 28082422
[TBL] [Abstract][Full Text] [Related]
32. Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Zhang P; Wang D; Zhao Y; Ren S; Gao K; Ye Z; Wang S; Pan CW; Zhu Y; Yan Y; Yang Y; Wu D; He Y; Zhang J; Lu D; Liu X; Yu L; Zhao S; Li Y; Lin D; Wang Y; Wang L; Chen Y; Sun Y; Wang C; Huang H
Nat Med; 2017 Sep; 23(9):1055-1062. PubMed ID: 28805822
[TBL] [Abstract][Full Text] [Related]
33. Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma.
Chen HY; Lin LT; Wang ML; Lee SH; Tsai ML; Tsai CC; Liu WH; Chen TC; Yang YP; Lee YY; Chang YL; Huang PI; Chen YW; Lo WL; Chiou SH; Chen MT
Oncotarget; 2016 Jul; 7(27):42485-42501. PubMed ID: 27285760
[TBL] [Abstract][Full Text] [Related]
34. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
[TBL] [Abstract][Full Text] [Related]
35. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206.
Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J
Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647
[TBL] [Abstract][Full Text] [Related]
36. Musashi 1-positive cells derived from mouse embryonic stem cells can differentiate into neural and intestinal epithelial-like cells in vivo.
Lan SY; Yu T; Xia ZS; Yuan YH; Shi L; Lin Y; Huang KH; Chen QK
Cell Biol Int; 2010 Dec; 34(12):1171-80. PubMed ID: 20670215
[TBL] [Abstract][Full Text] [Related]
37. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
[TBL] [Abstract][Full Text] [Related]
38. Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue.
Talebi-Yazdabadi Z; Jahanbakhsh N; Dormiani K; Forouzanfar M; Lachinani L; Zohrabi D; Tavalaee M; Nasr-Esfahani MH
Andrologia; 2021 Nov; 53(10):e14187. PubMed ID: 34309875
[TBL] [Abstract][Full Text] [Related]
39. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
Furusho M; Ishii A; Bansal R
J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
